The rebate allays fears of a 170% price rise but patients are warned the cost of the drug will still jump.

Source

The target set by the Department of Health for patients red flagged for breast cancer to be assessed is 14 days.

Source

The drug's US manufacturer has asked UK distributors to stop taking orders from pharmacies until next month's price increase.

Source